severe covid - Robuta Search

https://c19early.org/guisadovasco.html Guisado-Vasco: Clinical characteristics and outcomes among hospitalized adults with severe COVID-19... Guisado-Vasco, 607 patient HCQ late treatment study: 20% lower mortality (p=0.36). Retrospective 607 patients showing significantly lower mortality with... severe covid guisado vasco clinical characteristics https://c19early.org/sosagarcia.html Sosa-García: Experience in the management of severe COVID-19 patients in an intensive care unit... Sosa-García, 56 patient HCQ ICU study: 11% higher mortality (p=1). Small retrospective study of 56 ICU patients in Mexico showing HCQ RR 1.1, p = 1.0. -... severe covid intensive care sosa experience management https://c19early.org/afsin.html Afşin: Factors affecting prognosis and mortality in severe COVID-19 pneumonia patients [HCQ] Afşin, 80 patient HCQ late treatment study: 17% lower mortality (p=0.5). Retrospective 80 hospitalized severe COVID-19 patients in Turkey, showing no.. -... factors affecting severe covid prognosis mortality pneumonia https://c19early.org/delgado.html Delgado: Investigational medications in 9,638 hospitalized patients with severe COVID-19: lessons... Delgado, 9,638 patient HCQ late treatment study: 26% lower mortality (p=0.002). PSM retrospective 9,638 patients in the USA, showing significantly lower.. -... hospitalized patients severe covid delgado investigational medications https://c19early.org/darcis.html Darcis: Long-term clinical follow-up of patients suffering from moderate-to-severe COVID-19... Darcis, 199 patient HCQ late treatment study: 32% lower long COVID (p=0.58). Prospective observational study of 199 hospitalized COVID-19 patients in Belgium..... long term severe covid clinical follow patients https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2020.579944/full Frontiers | Paracetamol-Induced Glutathione Consumption: Is There a Link With Severe COVID-19... May 9, 2026 - COVID-19 pandemic is posing an unprecedented sanitary threat: antiviral and host-directed medications to treat the disease are urgently needed.A great effort... severe covid frontiers paracetamol induced glutathione https://c19early.org/byakikakibwika.html Byakika-Kibwika: Safety and Efficacy of Hydroxychloroquine for Treatment of Non-Severe COVID-19 in... Byakika-Kibwika, 105 patient HCQ late treatment RCT: no change in recovery (p=0.91) and 29% improved viral clearance (p=0.47). Small 105 patient RCT in... severe covid safety efficacy hydroxychloroquine treatment https://c19early.org/silva3.html Silva: Clinical-Epidemiology Aspect of Inpatients With Moderate or Severe COVID-19 in a Brazilian... Silva, 395 patient HCQ late treatment study: 46% higher mortality (p=0.22). Retrospective 395 hospitalized patients in Brazil, showing higher mortality with..... severe covid silva clinical epidemiology aspect https://digitalsupercluster.ca/impact-story/leveraging-ai-to-enhance-treatment-for-severe-covid-patients/ Leveraging AI to Enhance Treatment for Severe COVID Patients - DIGITAL Built in Canada. Ready for the World. leveraging ai severe covid enhance treatment patients https://www.nature.com/articles/s41598-023-31944-7?error=cookies_not_supported&code=5dafe23b-8514-414c-9619-58fb9ee92442 Mortality rates of severe COVID-19-related respiratory failure with and without extracorporeal... Apr 20, 2023 - The use of extracorporeal membrane oxygenation (ECMO) is discussed to improve patients’ outcome in severe COVID-19 with respiratory failure, but data on ECMO... severe covid mortality rates related respiratory https://c19early.org/burhan.html Burhan: Characteristics and outcomes of patients with severe COVID-19 in Indonesia: Lessons from... Burhan, 559 patient HCQ ICU study: 1% higher mortality (p=0.91). Retrospective 559 COVID-19 ICU patients in Indonesia, showing no difference in mortality... severe covid burhan characteristics outcomes patients https://c19early.org/sestili.html Sestili: Paracetamol-Induced Glutathione Consumption: Is There a Link With Severe COVID-19 Illness?... Discussion of the potential negative effects of acetaminophen for COVID-19 based on promotion of glutathione depletion, especially in population groups at.. -... severe covid paracetamol induced glutathione consumption https://c19early.org/alosaimi.html Alosaimi: Analyzing the Difference in the Length of Stay (LOS) in Moderate to Severe COVID-19... Alosaimi, 74 patient HCQ late treatment PSM study: 400% higher mortality (p=0.49), 43% shorter hospitalization (p=0.63), and 29% higher hospital discharge (p..... severe covid analyzing difference length stay https://c19early.org/goldmanh.html Goldman: Remdesivir for 5 or 10 Days in Patients with Severe Covid-19 [HCQ] Goldman, 397 patient HCQ late treatment study: 22% lower mortality (p=0.46). Study focused on remdesivir but with results for HCQ in the supplementary.. -... severe covid goldman remdesivir days patients https://c19early.org/guglielmetti.html Guglielmetti: Severe COVID-19 pneumonia in Piacenza, Italy – a cohort study of the first pandemic... Guglielmetti, 218 patient HCQ late treatment study: 35% lower mortality (p=0.22). Retrospective 218 hospitalized patients in Italy showing non-statistically..... severe covid cohort study pneumonia piacenza italy https://pubmed.ncbi.nlm.nih.gov/32530507/ Can steroids reverse the severe COVID-19 induced "cytokine storm"? - PubMed Severe coronavirus disease (COVID-19) is characterized by an excessive proinflammatory cytokine storm, resulting in acute lung injury and development of acute... severe covid steroids reverse induced cytokine https://c19early.org/chevalier.html Chevalier: CovAID: Identification of factors associated with severe COVID-19 in patients with... Chevalier, 1,213 patient HCQ prophylaxis study: 35% lower mortality (p=0.19) and 19% lower hospitalization (p=0.36). Retrospective 1,213 rheumatic disease.. -... severe covid chevalier identification factors associated https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0290964 Characteristics and outcomes of patients with severe COVID-19 in Indonesia: Lessons from the first... Background Indonesia’s national response to COVID-19 evolved rapidly throughout 2020. Understanding pandemic response and outcomes is crucial for better... severe covid characteristics outcomes patients indonesia https://c19early.org/hafez.html Hafez: Antiviral Used among Non-Severe COVID-19 Cases in Relation to Time till Viral Clearance: A... Hafez, 1,486 patient HCQ late treatment study: 12% faster viral clearance (p=0.59). Retrospective hospitalized patients in the United Arab Emirates, showing..... severe covid viral clearance hafez antiviral used https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2023.1152587/full Frontiers | CovAID: Identification of factors associated with severe COVID-19 in patients with... May 16, 2026 - a. IntroductionAutoimmune/inflammatory rheumatic diseases (AIRDs) patients might be at-risk of severe COVID-19. However, whether this is linked to the diseas... severe covid frontiers identification factors associated https://link.springer.com/epdf/10.1007/s40121-021-00496-6?error=cookies_not_supported&code=bc8d35eb-53f3-437a-bb31-445cf1b7cd2a Favipiravir and Hydroxychloroquine Combination Therapy in Patients with Moderate to Severe COVID-19... severe covid hydroxychloroquine combination therapy patients https://c19early.org/pham.html Pham: Failure of chronic hydroxychloroquine in preventing severe complications of COVID-19 in... Pham, 42 patient HCQ prophylaxis study: 20% lower mortality (p=0.77) and 35% higher ICU admission (p=0.61). Tiny retrospective database analysis of.. -... pham failure chronic hydroxychloroquine preventing https://www.riotimesonline.com/ncaa-golfer-has-severe-adverse-heart-condition-due-to-covid-vaccine-speaks-out-against-vaccine-mandates/ NCAA Golfer has severe adverse heart condition due to Covid vaccine, speaks out against vaccine... Sep 17, 2021 - RIO DE JANEIRO, BRAZIL - John Stokes, an Academic Medal of Honor student and a Division One golfer at Tennessee State University, developed myocarditis (heart i covid vaccine ncaa golfer severe adverse https://www.medrxiv.org/content/10.1101/2021.02.01.21250371v1 HYDROXYCHLOROQUINE FOR THE TREATMENT OF SEVERE RESPIRATORY INFECTION BY COVID-19: A RANDOMIZED... The novel coronavirus pandemic (COVID–19) represents a major public health problem due to its rapid spread and its ability to generate severe pneumonia. Thus,... hydroxychloroquine treatment severe respiratory infection https://www.immunopaedia.org.za/webinars/sais-immunopaedia-webinars/severe-vs-mild-covid-19-immunity-and-intersection-between-nicotinamide-pathway-covid-19/ Severe vs mild COVID-19 immunity and Nicotinamide pathway | Immunopaedia Immunopaedia Mar 24, 2022 - The South African Immunology Society (SAIS) in collaboration with Immunopaedia hosted a webinar that featured talks by Prof Clive Gray and Dr Melinda Suchard... severe vs mild covid immunity https://c19early.org/panda2.html SEV-COVID: Antiviral Combination Clinically Better Than Standard Therapy in Severe but Not in... Panda, 41 patient HCQ late treatment RCT: 48% lower mortality (p=0.45). RCT 111 patients in India in 5 groups: severe patients: a) standard treatment, b).. -... sev covid antiviral combination clinically https://expose-news.com/2024/10/16/covid-vaccine-hepatitis-children-who-health-alert/ #Concidence? – Study confirming COVID Vaccines cause Severe Autoimmune-Hepatitis was published days... Oct 16, 2024 - A scientific study published 21st April 2022, concluded that Covid-19 vaccination can elicit a distinct T cell-dominant immune-mediated hepatitis (liver... vaccines cause study confirming covid severe https://c19early.org/alghamdi2.html Alghamdi: Clinical characteristics and treatment outcomes of severe (ICU) COVID-19 patients in... Alghamdi, 171 patient HCQ ICU study: 39% higher mortality (p=0.52). Retrospective 171 ICU patients in Saudi Arabia showing no significant difference for HCQ..... clinical characteristics treatment outcomes severe https://c19early.org/galvezbarron.html Gálvez-Barrón: COVID-19: Clinical Presentation and Prognostic Factors of Severe Disease and... Gálvez-Barrón, 103 patient acetaminophen prophylaxis study: 47% higher mortality (p=0.42) and 23% lower severe cases (p=0.55). Analysis of 103 elderly.. -... covid clinical presentation prognostic factors